Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

iShares Biotechnology ETF (NQ: IBB )

133.14 -1.11 (-0.83%)
Official Closing Price Updated: 4:15 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
BioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously Optimistic
For the current year, BioNTech projected revenue of 1.7 billion euros to 2.2 billion euros, below the market consensus of 2.54 billion euros and a fall from last year's 2.75 billion euros. 
Via Stocktwits
Healthcare Sector Trying To Bounce Back
I often discuss highly rated stocks that are part of highly rated sectors. Thus, this time is a departure from the norm. Let's dive into the data for the healthcare sector. 
Via Talk Markets
Topics ETFs Stocks / Equities
March Came In Like A Lion - Key Sectors Are Looking For A Lamb
Looking at the monthly chart, XRT now sits back in economic contraction, or below the 23-month moving average. 
Via Talk Markets
Topics ETFs
Editas Medicine Stock Slides After-Hours On Bigger-Than-Expected Q4 Loss, But Retail Bulls Eye M&A Potential
The company expects its current cash position and retained portions of payments from its agreement with Vertex to support operations into the second quarter of 2027. 
Via Stocktwits
Is It Time To Shift Focus To Beaten-Down Healthcare Stocks As Volatility Soars?
Healthcare performed terribly in 2023 and 2024, falling while the market was soaring. Year-to-date, the sector has outperformed. Is it time to focus on the stocks and ETFs of this low-Beta sector as... 
Via Talk Markets
Topics ETFs Stocks / Equities
Major Sector ETFs Wildcard: Biotechnology
On the weekly chart, IBB is breaking under the 200-week moving average. 
Via Talk Markets
Topics ETFs
Biotech Rally Coming In Weeks Ahead?
Large cap biopharma and MedTech stocks are leading the healthcare sector higher. 
Via Talk Markets
Topics ETFs Stocks / Equities
Semiconductors Fail A Key Support Level - And More
It has been 2 years and 2 months since the ETF for Semiconductors SMH has traded below the 50-week moving average. 
Via Talk Markets
Topics ETFs
4 Sectors That Thrive When Inflation Runs Hot
Sticky inflation and higher-for-longer interest rates is causing a rotation out of technology stocks, here are four sectors for investors hunting for value 
Via MarketBeat
Topics Economy World Trade
Exposures Interest Rates Tariff
PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz?
The rally follows PepGen's release of early clinical data from its Phase 1 trial evaluating its therapy to treat a rare genetic disorder. 
Via Stocktwits
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH. 
Via Benzinga
The Inside Sectors Of The Economy Flash Warning
Zooming out to the weekly chart of TLT, we see a double bottom in play from the lows in October 2023 and January 2025. 
Via Talk Markets
Topics Commodities ETFs Economy
Exposures Economy
Solid Biosciences' Retail Following Swells Amid Stock's Best Run In A Year — What's Behind The Move?
Early-stage data from the company's gene therapy candidate SGT-003 for Duchenne muscular dystrophy (DMD) showed encouraging results. 
Via Stocktwits
Biotech Stocks Had A Good Week Despite Crosscurrents
It’s too early to account for the rally but in general one can say that there is a lot of speculation from both the retail side and hedge funds. 
Via Talk Markets
Topics ETFs Stocks / Equities
Do The Major Sector ETFs Love High Flying Stocks?
The major sector ETFs remain muted. Nothing screams wildly bullish or horribly bearish in the weekly charts. 
Via Talk Markets
Topics Cryptocurrencies ETFs
Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing
The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp. 
Via Stocktwits
Price Action Disputes Most Macro Narratives
Do you believe the economy is heading towards inflation? What about a recession? Are gold prices sending a warning? Read on for the answer. 
Via Talk Markets
Topics Economy Stocks / Equities
Exposures Economy
Can Biotech Stocks Survive The Precarious Macro?
We were having a nice rally in January 2025 until the reality of tariffs hit on Friday which killed the momentum developing off the mid-January lows. 
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
Compare/Contrast - Year Of The Yin Wood Snake 1965 And 2025
The Federal debt in 1965 was $322.3 billion. In 2025 it is at $36.24 trillion. The unemployment rate was 5.2%. Now it is at 4.1%. 
Via Talk Markets
Topics ETFs
Small- To Mid-Cap Biotech Trades Poised For Gains
On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these... 
Via Talk Markets
Topics ETFs Stocks / Equities
DeepSeek Is Not New - The Rotation Away From Tech Is
The technical aspect of DeepSeek is not new. The reaction to it though, is new. 
Via Talk Markets
Topics Commodities
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens
The brokerage pointed to the company’s recent discontinuation of its NTLA-3001 program for alpha-1 antitrypsin deficiency-associated lung disease, reducing near-term growth prospects. 
Via Stocktwits
Healthcare And Biotech Stocks Lag The Market Again
Biotech stocks got little help from the JPM Conference despite some recovery to the general market. 
Via Talk Markets
Topics Stocks / Equities
There May Still Be Time to Get in on These 3 Trending Biotechs
Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025. 
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
Major Sector ETFs January Trend Trade is Here
Transportation IYT chart is incredible. The price action Friday showed the attempt to take out the January trend trade range and then failed. 
Via Talk Markets
Topics ETFs
Inflation, Soft Landing, January Trend Trade Working Out
Sugar, as shown in the weekly chart, has broken down under the 200-WMA for the first time since December 2020. However, it is holding the August 2024 low. 
Via Talk Markets
Topics Commodities ETFs Economy
Exposures Interest Rates
Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ
Avadel Pharmaceuticals missed the fourth quarter sales estimate by 5.12%. Still, the sales of its narcolepsy drug, LUMRYZ rose by 150% YoY. 
Via Benzinga
The Major Sector ETFs Remain Technically Intact
As long as XRT holds 78.00, it’s back where it broke out from after a massive consolidation last year. 
Via Talk Markets
Topics Cryptocurrencies ETFs
Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks
The healthcare sector is lagging over the past year and recent quarter with the XLV flat for 2024 and down over 4% for the recent quarter. 
Via Talk Markets
Topics ETFs Stocks / Equities
Happy New Year Or Is It For The Major Sector ETFs?
Russell 2000 IWM, has a few key points of support to hold. $217 is one. The 50-week moving average at around $212.45 is another. 
Via Talk Markets
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.